Spina Bifida – A Complete Medical Guide

Overview

Spina bifida is a birth defect that occurs when the spine and spinal cord do not form properly during the first month of pregnancy. The neural tube, which eventually becomes the brain and spinal cord, fails to close completely, leaving an opening in the vertebrae. The condition ranges from very mild (occult spina bifida) to severe forms that cause paralysis and lifelong disability.

Who is affected? Spina bifida occurs in all races and socioeconomic groups, but it is slightly more common in females than males (about 55 % female). In the United States, approximately 1,500 babies are born with spina bifida each year, representing roughly 1 in 2,700 live births ¹. Worldwide prevalence varies from 0.3 to 10 per 1,000 births, with higher rates in regions with limited access to prenatal folic acid supplementation.

Symptoms

The clinical presentation depends on the type and level of the spinal lesion. The three main types are:

• Occult (hidden) spina bifida – a small gap in the vertebrae, often without visible skin changes.
• Meningocele – a sac of fluid protrudes through the opening, but the spinal cord remains largely intact.
• Myelomeningocele – the most severe form; a sac contains nerves and spinal fluid, leading to nerve damage.

Common signs and symptoms

• Physical opening or “lesion” on the back – may be covered by skin or a fluid‑filled sac.
• Muscle weakness or paralysis in the legs, varying from mild (difficulty walking) to severe (no movement below the lesion).
• Sensory loss – reduced feeling in the toes, feet, or legs.
• Bladder and bowel dysfunction – urinary incontinence, frequent infections, constipation.
• Hydrocephalus – excess fluid in the brain occurring in ~80 % of myelomeningocele cases; may cause an enlarged head or developmental delays.
• Spina bifida occulta – often asymptomatic; may be discovered incidentally on X‑ray.
• Orthopedic problems – clubfoot, scoliosis, hip dislocation.
• Learning difficulties – especially in children with hydrocephalus; ranges from mild to moderate.
• Skin breakdown – pressure sores over the lesion site if mobility is limited.

Causes and Risk Factors

Spina bifida is a multifactorial condition, meaning that both genetic and environmental influences play a role.

Primary causes

• Failure of neural tube closure between days 21–28 of gestation.
• Genetic variants in genes involved in folate metabolism (e.g., MTHFR, DHFR) increase susceptibility.

Risk factors

• Insufficient folic acid intake before conception and during early pregnancy – the strongest modifiable risk factor. Women who do not take 400 µg of folic acid daily have up to a 2–3 fold higher risk ².
• Maternal diabetes (especially uncontrolled pre‑gestational diabetes) raises risk by 2–5 times.
• Obesity (BMI ≥ 30) – associated with a 1.5–2 fold increase.
• Use of certain medications – anti‑seizure drugs such as valproate, carbamazepine, and topiramate.
• Family history – having a sibling or parent with spina bifida raises recurrence risk to about 1–5 %.
• Low socioeconomic status – often linked to reduced access to prenatal vitamins.

Diagnosis

Early detection allows for better planning and, in some cases, prenatal intervention.

Prenatal screening

• Maternal serum α‑fetoprotein (AFP) – elevated levels at 15–20 weeks suggest an open neural tube defect.
• Ultrasound – detailed anatomy scan (18–22 weeks) can visualize the spinal lesion, measure lesion level, and assess for hydrocephalus.
• Amniocentesis – may be performed if AFP is high; amniotic fluid AFP and acetylcholinesterase are highly specific.

Post‑natal evaluation

• Physical examination – inspection of the back, assessment of motor function, reflexes, and sensation.
• Imaging:
  • Radiographs – visualize vertebral defects.
  • MRI – defines spinal cord involvement, syringomyelia, and associated brain abnormalities.
  • CT scan – useful for detailed bone anatomy if MRI contraindicated.
• Neurological testing – nerve conduction studies when motor/sensory deficits are uncertain.
• Renal ultrasound – screens for urinary tract complications.
• Head ultrasound (infants) or MRI – evaluates hydrocephalus.

Treatment Options

Treatment is individualized, aiming to correct structural defects, protect neurological function, and promote independence.

Surgical interventions

• Fetal surgery (in‑utero repair) – performed before 26 weeks in specialized centers; reduces need for shunting and improves motor outcomes in some cases ³.
• Post‑natal closure of the lesion – typically within the first 48 hours after birth to prevent infection and further nerve damage.
>
• Hydrocephalus management – ventriculoperitoneal (VP) shunt or endoscopic third ventriculostomy (ETV) to drain excess cerebrospinal fluid.
>
• Orthopedic surgeries – tendon lengthening, spinal fusion for scoliosis, foot reconstruction.

Medications & ongoing therapies

• Antibiotics – prophylactic treatment for urinary tract infections.
• Anticholinergic agents (e.g., oxybutynin) – help manage overactive bladder.
• Botulinum toxin injections – reduce spasticity in affected muscles.
• Pain management – NSAIDs, neuropathic pain agents (gabapentin, pregabalin) as needed.

Rehabilitative & supportive care

• Physical therapy – gait training, stretching, strengthening.
• Occupational therapy – adaptive equipment, wheelchair fitting.
• Assistive devices – braces, walkers, power‑assist wheelchairs.
• Educational support – individualized education plans (IEPs) for learning challenges.

Living with Spina Bifida

Successful long‑term management focuses on independence, skin integrity, and organ health.

Daily self‑care tips

• Skin checks – examine the back, legs, and any pressure points twice daily; use moisturizers to keep skin supple.
• Bladder program – scheduled voiding, intermittent catheterization if recommended, and adequate fluid intake (aim for 1.5–2 L/day unless restricted).
• Bowel regimen – consistent high‑fiber diet, regular timed toileting, stool softeners to avoid constipation.
• Exercise – low‑impact activities (swimming, stationary biking) improve circulation and muscle tone.
• Nutrition – balanced diet rich in folate, calcium, vitamin D; monitor weight to reduce joint stress.
• Regular follow‑up – neurology, urology, orthopedic, and rehabilitation appointments at least annually.

Psychosocial considerations

Living with a chronic condition can affect self‑esteem and mental health. Access to counseling, peer support groups (e.g., Spina Bifida Association), and vocational training improves quality of life.

Prevention

While genetics cannot be changed, many cases are preventable with public‑health measures.

• Folic acid supplementation – 400 µg daily for all women of childbearing age; 4 mg daily for those with a previous child with a neural tube defect or on anti‑seizure medication ⁴.
• Optimizing maternal health – maintain healthy weight, control diabetes, and avoid smoking or alcohol.
• Medication review – discuss alternative seizure medications with a neurologist before conception.
• Prenatal care – early ultrasound and AFP screening to identify at‑risk pregnancies.

Complications

If not managed appropriately, spina bifida can lead to serious health issues.

• Progressive neurological decline – worsening motor function or new sensory loss.
• Hydrocephalus complications – shunt malfunction, infections, or over‑drainage.
• Renal damage – recurrent UTIs, hydronephrosis, eventual kidney failure.
• Pressure ulcers – especially in individuals with reduced sensation.
• Orthopedic deformities – severe scoliosis, hip subluxation, limb contractures.
• Psychiatric issues – depression, anxiety, social isolation.

When to Seek Emergency Care

---

**References**

1. Centers for Disease Control and Prevention. Spina Bifida Fact Sheet. https://www.cdc.gov/ncbddd/spinabifida/data.html
2. World Health Organization. Folic Acid Supplementation. https://www.who.int/nutrition/topics/folic_acid/en/
3. National Heart, Lung, and Blood Institute. Fetal Surgery for Spina Bifida. https://www.nhlbi.nih.gov/health-topics/fetal-surgery
4. Mayo Clinic. Neural Tube Defects: Prevention and Treatment. https://www.mayoclinic.org/diseases-conditions/spina-bifida/diagnosis-treatment/drc-20354021
5. Cleveland Clinic. Spina Bifida Overview. https://my.clevelandclinic.org/health/diseases/17044-spina-bifida